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Abstract Cardiorespiratory fitness is one of the most im-
portant indicators of health and improves length of life. The
attention and acceptance for endurance training in patients
with several cancer diagnoses increased during the last
decade. This review highlight’s the effect of endurance
training in cancer patients by summarizing exemplary ran-
domized clinical trials and systematic reviews both within
the acute hospital treatment context, as in a rehabilitation
setting. To date, most studies focus on endurance training in
patient groups with moderate to good prognosis. The studies
within these patient groups evaluate the endurance training
in cancer patients using a moderate training intensity be-
tween 50 and 75 % of the VO2 peak with an exercise time
varying from 20 min (five times per week) in hospital up to
45 min (two to three times per week) in an ambulatory
setting. Recently, the American College of Sports Medicine
indicated that cancer survivors should follow the Physical
Activity Guidelines for Americans, which represents
≥150 min per week of moderate intensity, ≥75 min per week
of vigorous intensity aerobic exercise, or an equivalent
combination of moderate and vigorous intensity aerobic
exercises. To date, fewer studies evaluate the effects of
endurance training in a palliative setting to maintain physi-
cal function of the patient. Future studies should investigate
the effect of endurance training by evaluating different types
of intensity training (moderate vs. high intensity training),
the use of high-tech devices to improve physical activity,
and to evaluate the effect of endurance training in patients
with a palliative intention.
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Majority of the patients with oncological diseases are
suffering from deconditioning and fatigue during and
after completion of cancer treatment [16, 21, 24, 26,
32, 37]. These circumstances may last, even if patients
surpassed the completion of the oncological therapy.
This often leads to a reduced physical performance
and a decline of all daily activities of cancer patients.
As a result, patients may be restricted in their social
life, which may negatively influence the patient’s qual-
ity of life [22].
A growing amount of evidence documents the posi-
tive effect of aerobic endurance training, both during
and shortly after the oncological treatment [32]. Endur-
ance training is an essential component of physical
training and has gathered an important role in the
(early) rehabilitation of oncological patients during the
last decade [2, 16, 21, 25, 32].
An increase of the aerobic capacity is not only asso-
ciated with a decrease of the infamous fatigue syn-
drome, but also with a significant improvement in the
overall quality of life during and after the oncological
treatment therapy [32]. Yet, the effectiveness of the
endurance training in patients with oncological disease
is influenced by several factors, such as time point of
implementation of the endurance training (during or
after the oncological treatment), stage of cancerous dis-
ease, type and degree of seriousness of the oncological
treatment, and lifestyle of the patient [22].
The intention of this narrative review is to summarize
and highlight exemplary randomized clinical trials and
systematic reviews (meta-analyses) of aerobic exercise
training in oncological patients during and shortly after
cancer treatment both within the stationary treatment
R. H. Knols (*)
Physiotherapy & Occupational Therapy Research,




Eur Rev Aging Phys Act (2013) 10:47–52
DOI 10.1007/s11556-012-0117-1
context, as in an ambulatory rehabilitation setting. Fur-
thermore, the effects of endurance training in a pallia-
tive setting are presented. Finally, recommendations for
aerobic exercise training are discussed. The results of
the study analysis regarding the effects of endurance
training are summarized in Table 1.
Endurance training within the stationary treatment
context
Endurance training after hematological stem cell
transplantation
The effects of endurance training on aerobic capacity
after hematological stem cell transplantation in hospital
have been examined by Baumann et al. [3], Jarden et
al. [19] and Wiskemann et al. [36]. The training group
consisting of 64 participants (five times weekly, 10–
20 min, 80 % of VO2 max.) stabilized the intensity of
the performance workload and the patients’ activities of
daily living, following a supervised endurance training
(on stationary ergometer) during the stem cell transplan-
tation treatment [3]. The results of this study were equal
to those in the study of Jarden et al. [19]. These
patients carried out a combined endurance training (five
times weekly, 15–30 min, 50–75 % of the maximum
heart rate) combined with a resistive strength program
and stretch and relaxation exercises.
The study of Wiskemann et al. [36] showed an improve-
ment of the walking distance after a combined endurance
and muscle training program which started 1–4 weeks be-
fore the transplantation procedure and ended 6–8 weeks
after discharge from hospital (endurance training is three
to five times weekly for 20–40 min).
Lung cancer patients
Directly after thoracotomy, 58 large cellular lung carci-
noma patients were treated by a combined mobilization
and muscle training program in a hospital (maximum
heart rate was calculated by the formula 220 − age). A
home endurance training program was added to the
physical exercise training program in the hospital
(12 weeks, content and intensity of the program are not
clearly described). The exercise group was compared to a
non-exercise control group. At baseline, the 6-min walk-
ing test decreased in both groups (5 days after surgery).
However, both groups returned to the performance level
(before the surgical intervention) at the end of the exer-
cise program. This study could not show a benefit of
endurance training on aerobic capacity in lung cancer
patients compared to non-exercising controls [1].
Lymphoma patients
Courneya et al. [10] presented an example of the effective-
ness of aerobic exercise training in lymphoma patients dur-
ing adjuvant chemotherapy treatment. The included patients
carried out an aerobic endurance training program between
the chemotherapy cycles (12-week training program, thrice
weekly, bicycle ergometer, 60–75 % of VO2 max.). During
the first 4 weeks of the exercise program, patients exercised
15–20 min on a bicycle ergometer. Then, the time limit
increased 5 min per week until 40–45 min of endurance
training was achieved. During weeks 7 and 9, interval
Table 1 Monitored randomized studies on endurance training during different stages of illness
Time of intervention Phase of endurance training Intervention Structure of intervention Results regarding endurance




with daily life activities or
physical muscle training
Daily activity, duration (per unit)
is up to 20 min at start, more
an interval training, intensity is
moderate, physical activity is
50–75 % of the maximum
heart rate, Borg scale is 11–14
More likely a stabilizing
endurance effect






Endurance training (two to three
times per week), duration
(per unit) is 15–30 min at
60–75 % of the maximum
heart rate
More of an improvement
regarding endurance











Palliative phase Armchair fitness device Moderate physical activity (Borg
scale 13–15, up to 80 % of the
maximum heart rate)
Effect on endurance still
pending
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training (estimated VO2 peak. level above 75 %) was added
to the basic aerobic training. The chemotherapeutic treat-
ment was not disturbed during the endurance training. Yet, 3
of the 60 patients in the endurance group developed mus-
culoskeletal problems (back, hip, or knee) and therefore had
to apply an easier workout schedule. After 12 weeks of
training, the oxygen intake capacity increased significantly
in the endurance group (n=60), while patients in the control
group (n=62) showed a decrease of the aerobic capacity.
During adjuvant therapy in ambulatory hospital
Breast cancer
The effects of an endurance training on the aerobic capacity
of early stage breast cancer patients [9] during adjuvant
therapy (chemotherapy, radiotherapy, and hormone therapy)
provided good results after a supervised ergometer training
during 18 weeks in 78 patients (thrice weekly, 15–45 min,
estimated VO2 max. level 70–80 %). Yet, Segal et al. [30]
could not show any difference in aerobic capacity between a
supervised running program (33 participants), a home run-
ning program (32 participants), and a control group (34
participants). The study endured 26 weeks and included
physical exercise training (three to five times per week,
50–60 % of the VO2 max.).
Prostate cancer
The effects of an endurance training on the aerobic
capacity in prostate cancer patients during ambulatory
radiotherapy provided good results after a 24-week su-
pervised ergometer program, including 40 participants
(thrice weekly, 15–45 min, 50–75 % of the maximal
oxygen uptake capacity) [31].
The study of Windsor et al. [35] reported the effect of a
home-based physical training program (running, thrice
weekly, 50–60 % of the maximum heart rate during
26 weeks). The modified shuttle run test improved in the
endurance group (33 participants). The quality of life and
level of well-being also improved as a result of the super-
vised endurance training [35].
Furthermore, two studies examined the effects of a
combined strength and endurance training program,
reporting either the feasibility of a home-based walking
program (16 weeks, three to five times weekly [11] or a
supervised endurance training (ride bicycle or walking/
running, twice weekly, 15–20 min, at 65–80 % of the
maximum heart rate) [14] in prostate cancer patients
receiving hormone treatment. These physical exercise
programs lead to an improvement in physical fitness,
quality of life, and fatigue.
Shortly after medical treatment
Breast cancer patients
A supervised ergometer endurance training program
(15 weeks, thrice weekly, up to 35 min, at 70–75 % of the
maximal oxygen uptake capacity) after adjuvant therapy
improved the aerobic capacity of 25 breast cancer patients
[8], compared to a non-exercising control group. Daley et al.
[12] examined the effect of a monitored running program
(8 weeks, thrice weekly, 60–85 % of the maximum heart rate
adapted to age) on walking distance. Walking distance in-
creased significantly after completion of the running pro-
gram in the exercise group compared to the placebo and
control groups. The study of Rogers et al. [28] could not
demonstrate any significant difference between 21 patients
participating in a home-based running program (12 weeks,
150 min weekly at 85 % of the maximum heart rate) and 21
control patients assessed with the Naughton treadmill test.
Colorectal cancer
Courneya et al. [6] examined the impact of a self-monitored
running program in 102 colorectal cancer patients after
surgery. The researchers found an increase in the walking
distance among both the running and the control groups,
whereas there was no statistical difference between the
walking performance of both groups (duration of the run-
ning program 15 weeks, three to five times weekly, mini-
mum loading time 20–30 min, 60–75 % of the maximum
heart rate).
Patients with anemia
Courneya et al. [7] also examined the effect of a supervised
bicycle ergometer program (12 weeks, three to five times
weekly, 20–45 min, >60 % of the maximal oxygen uptake
capacity) in 55 non-myeloid anemic cancer patients after
chemotherapy. Both the physical exercise and the control
groups received darbepoetine alpha during chemotherapy
treatment. A significant difference regarding the oxygen
intake capacity could be retrieved between the training and
the control groups. Although the improvement of the oxy-
gen uptake capacity in the exercise group was larger, no
statistical difference concerning fatigue or quality of life
could be pointed out between both groups.
Patients after hematological stem cell transplantation
The improvement of the 6-min walking test in the combined
endurance and strengthening program group, including 64
allogeneic and autologous patients after stem cell transplan-
tation (12 weeks, twice weekly, minimum 20 min of walking
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or cycling in an ambulatory setting, up to 75 % of the maxi-
mum heart rate), was statistically significant compared to the
6-min walking test result of the control group [23].
Patients with various types of cancer
Dimeo et al. [13] reported a significant increase of the
performance intensity in the endurance training group (bi-
cycle ergometer during 3 weeks, five times weekly, up to
30 min, 50 rpm, at 80 % of the maximum heart rate)
compared to the control group, which was instructed to
perform the Jacobson muscle relaxation method. This study
was postoperatively performed in the hospital in 51 patients
with either lung, rectal, colonic, gastric, or sigmoid cancer.
Thorsen et al. [33] observed a 23 % increase of the maxi-
mum oxygen intake capacity in the endurance training group of
111 lymphoma, breast, testical, and gynecological cancer
patients during chemotherapy treatment. The running and self-
monitored home program endured 14 weeks (twice per week,
minimum load duration 30 min, 60–70 % of the maximum
heart rate, at a Borg scale of 13 “somewhat hard–steady pace” to
15 “hard”). The maximal oxygen uptake capacity of the control
group improved also without physical exercise training (10 %).
The effect of a supervised endurance training program on
the maximal oxygen uptake capacity of oncological patients
was analyzed in a meta-analysis. Six studies were included,
analyzing a total of 571 patients (endurance group, 344
patients; control group, 227 patients). The meta-analyses
showed an improvement of the maximal oxygen uptake
capacity in favor of the endurance training group. Another
important conclusion of this review is that mainly oncolog-
ical patients in the early cancer stages may benefit from the
endurance training [20].
Effects of an endurance training on advanced cancer
patients treated with a palliative intention
Headley et al. [18] investigated the effect of an armchair
fitness device (fitness while seated, 12 weeks, thrice week-
ly) on fatigue in comparison to a non-active control group in
38 breast cancer patients (stage IV). The result of this study
yielded positive results for fatigue symptomatology in the
training group. The fatigue level in the exercise group
increased significantly slower than the non-exercising
patients in the control group. A specific endurance effect
was not assessed in this study.
Methodological quality
Earlier systematic reviews indicated that many of the RCTs
undertaken to evaluate the effectiveness of exercise programs
in cancer patients have been of only moderate methodological
quality. However, since the introduction of criteria list for
surveys of methodological concern regarding randomized
studies, e.g., Delphi list [34], the quality of trials improved
significantly from moderate to good in the second half of the
last decade [22, 32]. However, some studies still fail to report a
statement about important methodological quality criteria
such as the blinding of examiner or exercise therapist, the
concealment of group assignment, and the implementation of
an intention-to-treat analysis. Reporting of these items may
reduce the level of bias in randomized clinical trials. Further-
more, bias between randomized controlled studies in meta-
analyses may also be caused by heterogeneity of the research
designs of the studies, such as different therapeutic dosages or
exercise strategies [27].
Recommendations for a disease-specific training
Oncological patients in ambulatory hospital settings should,
if possible, perform an aerobic endurance training on a daily
basis (15–30 min, at 50–75 % of the maximum heart rate).
Patients in an ambulatory setting treated with (adjuvant)
chemotherapy, radiotherapy, or hormonal therapy and
patients in a rehabilitation setting following an exercise
program directly after medical treatment should perform
an endurance training program up to 45 min, at least two
to three times weekly, in order to accomplish a safe and
effective training. These patients should strive for a training
intensity of 60–80 % of the maximum heart rate or for 50–
75 % of the maximal oxygen uptake capacity. The endur-
ance training should ideally be conducted using a bicycle
ergometer or treadmill, because the physical performance
level may be monitored continually.
Walking outdoors can also be a useful activity in order to
improve endurance. It is recommended that the patient car-
ries a heart rate monitor or pedometer to keep the physical
effort during the walking training under surveillance.
Patients with no or little experience in physical exercise,
patients who are suffering from severe side effects of the
anti-cancer treatment or of an additional chronic disease
should start with a daily training of lower intensity (10–
15 min) or by means of a moderate interval training in order
to achieve the desired overall duration [17]. According to
current evidence, endurance training can be well-combined
with resistive strength training. In order to prevent severe
overload of the physical training, it is suggested to perform
the endurance training on 2–3 days/week and to perform
strength training on two other days [29].
The participation in endurance training is contraindicated
in case of the following: acute hemorrhage, thrombocytope-
nia (below 10,000 units per μL blood), severe pain or
infection, severe cardio-pulmonary complaints, and fever
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over 38 °C. Nausea and vomiting, days in which patients
receive cardio- or nephrotoxic chemotherapy treatment, pal-
lor, vomiting, headache, vertigo, and hyperventilation may
challenge the participation of physical exercise training [4].
Supervised endurance training is a safe and efficient method
in order to stabilize or improve the aerobic capacity in cancer
patients with different diagnoses in early and advanced stages.
Endurance training can be applied in order to stabilize the
aerobic capacity in hospital or in the ambulatory phase during
medical treatment. In the rehabilitation phase (starting imme-
diately after completing anti-cancer treatment), aerobic capac-
ity will increase after an endurance training of 12–18 weeks at
a frequency of two to three times per week. Endurance training
(combined with resistive strength training) can improve the
quality of life and reduce fatigue symptomatology. The bene-
fits of endurance training were particularly gained when ap-
plied in patients with an early cancer. Currently, there is only
few evidence that reports the effect of endurance training in
patients with advanced cancer stages. Thus, further studies
should examine the appropriate training program for palliative
patients in order to improve aerobic capacity.
However, despite the growing evidence of physical exer-
cise training to improve aerobic capacity, the main princi-
ples of exercise training (i.e., specificity, overload,
progression, initial values, reversibility, and diminishing
returns) are not always included in the exercise protocols
for cancer patients. By following the principles of exercise
training and thoroughly reporting all components of the
exercise prescription and adherence, specific evidence-
based exercise prescriptions administered by healthcare pro-
fessionals could be available for cancer patients and survi-
vors in the near future [5]. Yet, even though the direct effects
of aerobic exercise on cancer patients during and directly
after medical treatment are not definitively proven, given
that physical exercise is generally safe and improves aerobic
capacity and quality of life especially in early cancer stages,
and has numerous other health benefits, adequate physical
exercise should be a standard part of cancer care [15].
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